Showing results (221-230 of 465) with videos related to

Sort By:
Pageof 47
Molecular and Clinical Oncology|November 18, 2021
Risk of penile tumor development in Caucasian individuals is independent of the coding variant rs7208422 in the TMC8 (EVER2) geneRobert Stoehr, Olaf Wendler, Johannes Giedl, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|March 2, 2012
Mismatch repair proteins hMLH1 and hMSH2 are differently expressed in the three main subtypes of sporadic renal cell carcinomaChristine Stoehr, Maximilian Burger, Robert Stoehr, et al.
JPRAS Open|January 16, 2025
Functional soft palate reconstructionSofia Oetliker-Contin, Tarek Ismail, Rik Osinga, et al.
World Journal of Urology|April 10, 2013
Is gender becoming relevant in uro-oncological research? A bibliographical analysisFrank Kunath, Bastian Keck, Simone Bertz, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 13, 2020
The comprehensive complication index is associated with a significant increase in complication severity between 30 and 90 days after radical cystectomy for bladder cancerMaximilian Haas, Toni Huber, Christoph Pickl, et al.
BMC Urology|September 5, 2018
Expression, localisation and potential significance of aquaporins in benign and malignant human prostate tissueJohannes Bründl, Sabine Wallinger, Johannes Breyer, et al.
American Journal of Clinical Pathology|September 22, 2010
Multicolor FISH (UroVysion) facilitates follow-up of patients with high-grade urothelial carcinoma of the bladderHans-Martin Fritsche, Maximilian Burger, Wolfgang Dietmaier, et al.
European Urology|March 3, 2012
Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literatureGiovanni Lughezzani, Maximilian Burger, Vitaly Margulis, et al.
International Journal of Molecular Sciences|November 1, 2013
MiR-205 is progressively down-regulated in lymph node metastasis but fails as a prognostic biomarker in high-risk prostate cancerCharis Kalogirou, Martin Spahn, Markus Krebs, et al.
Pageof 47